Sean Gaine
- Pulmonary Hypertension
Edited by Marius M. Hoeper and Marc HumbertBook | Published in 2012DOI: 10.1183/1025448x.erm5712ISBN (electronic): 978-1-84984-026-2 - Challenges in the diagnosis and treatment of pulmonary arterial hypertensionBy Jean-Luc Vachiéry and Sean GaineJean-Luc Vachiéry*Pulmonary Vascular Diseases and Heart Failure Clinic, Cliniques Universitaires de Bruxelles, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium. #National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland.Sean Gaine*Pulmonary Vascular Diseases and Heart Failure Clinic, Cliniques Universitaires de Bruxelles, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium. #National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland.
- The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertensionBy Sean Gaine and Gérald SimonneauSean Gaine1National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland. 2Service de Pneumologie, Hôpital Universitaire de Bicêtre, Université Paris-Sud, Le Kremlin Bicêtre, France.Gérald Simonneau1National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland. 2Service de Pneumologie, Hôpital Universitaire de Bicêtre, Université Paris-Sud, Le Kremlin Bicêtre, France.
- A role for the CXCL12 receptor, CXCR7, in the pathogenesis of human pulmonary vascular diseaseBy Christine M. Costello, Brian McCullagh, Katherine Howell, Michelle Sands, John A. Belperio, Michael P. Keane, Sean Gaine and Paul McLoughlinChristine M. CostelloBrian McCullaghKatherine HowellMichelle SandsJohn A. BelperioMichael P. KeaneSean Gaine
- Late-breaking abstract: Demographic trends and changes In long term outcome of incident idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension between 2001 to 2009. Results from the Pulmonary Hypertension Registry of the United Kingdom and IrelandBy Yi Ling, Martin Johnson, David Kiely, Robin Condliffe, Charlie Elliot, Simon Gibbs, Luke Howard, Joanna Pepke-Zaba, Karen Sheares, Paul Corris, Andrew Fisher, Jim Lordan, Sean Gaine, Gerry Coghlan, John Wort, Michael Gatzoulis and Andrew PeacockYi Ling1Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Clydebank, United KingdomMartin Johnson1Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Clydebank, United KingdomDavid Kiely2Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, United KingdomRobin Condliffe2Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, United KingdomCharlie Elliot2Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, United KingdomSimon Gibbs3Pulmonary Hypertension Service, Hammersmith Hospital, London, United KingdomLuke Howard3Pulmonary Hypertension Service, Hammersmith Hospital, London, United KingdomJoanna Pepke-Zaba4Pulmonary Vascular Disease Unit, Papworth Hospital, Papworth, United KingdomKaren Sheares4Pulmonary Vascular Disease Unit, Papworth Hospital, Papworth, United KingdomPaul Corris5Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle, United KingdomAndrew Fisher5Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle, United KingdomJim Lordan5Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle, United KingdomSean Gaine6Pulmonary Hypertension Unit, Mater Misericordiae Hospital, Dublin, IrelandGerry Coghlan7Pulmonary Hypertension Unit, Royal Free Hospital, London, United KingdomJohn Wort8Royal Brompton Pulmonary Hypertension and Adult Congenital Heart Centre, Royal Brompton Hospital, London, United KingdomMichael Gatzoulis8Royal Brompton Pulmonary Hypertension and Adult Congenital Heart Centre, Royal Brompton Hospital, London, United KingdomAndrew Peacock1Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Clydebank, United Kingdom
- Late-breaking abstract: Short term improvement in 6 minute walk distance predicts long term survival in incident idiopathic pulmonary arterial hypertension. Results from the Pulmonary Hypertension Registry of the United Kingdom and IrelandBy Yi Ling, Martin Johnson, David Kiely, Robin Condliffe, Charlie Elliot, Simon Gibbs, Luke Howard, Joanna Pepke-Zaba, Karen Sheares, Paul Corris, Andrew Fisher, Jim Lordan, Sean Gaine, Gerry Coghlan, John Wort, Michael Gatzoulis and Andrew PeacockYi Ling1Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Clydebank, United KingdomMartin Johnson1Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Clydebank, United KingdomDavid Kiely2Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, United KingdomRobin Condliffe2Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, United KingdomCharlie Elliot2Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, United KingdomSimon Gibbs3Pulmonary Hypertension Service, Hammersmith Hospital, London, United KingdomLuke Howard3Pulmonary Hypertension Service, Hammersmith Hospital, London, United KingdomJoanna Pepke-Zaba4Pulmonary Vascular Disease Unit, Papworth Hospital, Papworth, United KingdomKaren Sheares4Pulmonary Vascular Disease Unit, Papworth Hospital, Papworth, United KingdomPaul Corris5Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle, United KingdomAndrew Fisher5Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle, United KingdomJim Lordan5Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle, United KingdomSean Gaine6Pulmonary Hypertension Unit, Mater Misericordiae Hospital, Dublin, IrelandGerry Coghlan7Pulmonary Hypertension Unit, Royal Free Hospital, London, United KingdomJohn Wort8Royal Brompton Pulmonary Hypertension and Adult Congenital Heart Centre, Royal Brompton Hospital, London, United KingdomMichael Gatzoulis8Royal Brompton Pulmonary Hypertension and Adult Congenital Heart Centre, Royal Brompton Hospital, London, United KingdomAndrew Peacock1Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Clydebank, United Kingdom
- emPHasis-10: development of a health-related quality of life measure in pulmonary hypertensionBy Janelle Yorke, Paul Corris, Sean Gaine, J. Simon R. Gibbs, David G. Kiely, Carl Harries, Val Pollock and Iain ArmstrongJanelle Yorke1School of Nursing, Midwifery and Social Work, University of Manchester, ManchesterPaul Corris2Dept of Respiratory Medicine, Freeman Hospital, Newcastle upon TyneSean Gaine3Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, IrelandJ. Simon R. Gibbs4National Heart and Lung Institute, Imperial College London, London5Pulmonary Hypertension Service, Hammersmith Hospital, LondonDavid G. Kiely6Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, SheffieldCarl Harries7Pulmonary Hypertension Unit, Royal Brompton and Harefield Foundation NHS Trust, LondonVal Pollock8Scottish Vascular Unit, Golden Jubilee National Hospital, GlasgowIain Armstrong6Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield9Pulmonary Hypertension Association UK, Rotherham, UK
- 'Idiopathic' pulmonary arterial hypertension with preserved lung function but co-existing parenchymal abnormalities: Response to treatment and survivalBy Yi Ling, Martin Johnson, David Kiely, Robin Condliffe, Charlie Elliot, J. Simon R Gibbs, Luke Howard, Joanna Pepke-Zaba, Karen Sheares, Paul Corris, Andrew Fisher, James Lordan, Sean Gaine, J. Gerry Coghlan, S. John Wort, Michael Gatzoulis and Andrew PeacockYi Ling1Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, United KingdomMartin Johnson1Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, United KingdomDavid Kiely2Sheffield Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, United KingdomRobin Condliffe2Sheffield Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, United KingdomCharlie Elliot2Sheffield Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, United KingdomJ. Simon R Gibbs3National Heart and Lung Institute, Imperial College London and Hammersmith Hospital, London, United KingdomLuke Howard3National Heart and Lung Institute, Imperial College London and Hammersmith Hospital, London, United KingdomJoanna Pepke-Zaba4Pulmonary Vascular Disease Unit, Papworth Hospital, Cambridge, United KingdomKaren Sheares4Pulmonary Vascular Disease Unit, Papworth Hospital, Cambridge, United KingdomPaul Corris5Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle, United KingdomAndrew Fisher5Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle, United KingdomJames Lordan5Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle, United KingdomSean Gaine6National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, IrelandJ. Gerry Coghlan7Pulmonary Hypertension Unit, Royal Free Hospital, London, United KingdomS. John Wort8Royal Brompton Pulmonary Hypertension and Adult Congenital Heart Centre, Brompton Hospital, London, United KingdomMichael Gatzoulis8Royal Brompton Pulmonary Hypertension and Adult Congenital Heart Centre, Brompton Hospital, London, United KingdomAndrew Peacock1Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, United Kingdom
- emPHasis-10: development of a health-related quality of life measure in pulmonary hypertensionBy Janelle Yorke, Paul Corris, Sean Gaine, Simon S Gibbs, David G Kiely, Carl Harries, Val Pollock and Iain ArmstrongArticle | Published in 2013 in European Respiratory JournalJanelle Yorke*School of Nursing, Midwifery and Social Work, University of Manchester, Manchester UKPaul Corris#Dept of Respiratory Medicine, Freeman Hospital, Newcastle UKSean Gaine¶Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, IrelandSimon S Gibbs+National Heart and Lung Institute, Imperial College London UK§Pulmonary Hypertension Service, Hammersmith Hospital, London UKDavid G KielyfSheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UKCarl Harries**Pulmonary Hypertension Unit, Royal Brompton and Harefield Foundation NHS Trust, London UKVal Pollock##Scottish Vascular Unit, Golden Jubilee National Hospital, Glasgow UKIain ArmstrongfSheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK¶¶Pulmonary Hypertension Association UK, Sheffield UK
- emPHasis-10: development of a health-related quality of life measure in pulmonary hypertensionBy Janelle Yorke, Paul Corris, Sean Gaine, Simon S Gibbs, David G Kiely, Carl Harries, Val Pollock and Iain ArmstrongArticle | Published in 2013 in European Respiratory JournalJanelle Yorke*School of Nursing, Midwifery and Social Work, University of Manchester, Manchester UKPaul Corris#Dept of Respiratory Medicine, Freeman Hospital, Newcastle UKSean Gaine¶Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, IrelandSimon S Gibbs+National Heart and Lung Institute, Imperial College London UK§Pulmonary Hypertension Service, Hammersmith Hospital, London UKDavid G KielyfSheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UKCarl Harries**Pulmonary Hypertension Unit, Royal Brompton and Harefield Foundation NHS Trust, London UKVal Pollock##Scottish Vascular Unit, Golden Jubilee National Hospital, Glasgow UKIain ArmstrongfSheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK¶¶Pulmonary Hypertension Association UK, Sheffield UK
- Portopulmonary hypertension in United Kingdom: A contemporary, national, observational studyBy Sasiharan Sithamparanathan, Logan Thirugnanasothy, Arun Nair, Gerry Coghlan, Charles Elliot, Andrew Fisher, Sean Gaine, Simon Gibbs, Michael Gatzoulis, Clive Handler, Luke Howard, Michael Johnson, David Kiely, James Lordan, Andrew Peacock, Joanna Pepke-Zaba, Ian Sabroe, Karen Sheares, Stephen Wort and Paul CorrisSasiharan Sithamparanathan1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomLogan Thirugnanasothy1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomArun Nair1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomGerry Coghlan1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomCharles Elliot1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomAndrew Fisher1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomSean Gaine1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomSimon Gibbs1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomMichael Gatzoulis1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomClive Handler1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomLuke Howard1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomMichael Johnson1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomDavid Kiely1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomJames Lordan1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomAndrew Peacock1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomJoanna Pepke-Zaba1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomIan Sabroe1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomKaren Sheares1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomStephen Wort1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomPaul Corris1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United Kingdom
- Effect of selexipag on long-term outcomes in key subgroups of patients with pulmonary arterial hypertension (PAH): GRIPHON study resultsBy Olivier Sitbon, Richard Channick, Kelly Chin, Aline Frey, Nazzareno Galiè, Hossein-Ardeschir Ghofrani, Marius M. Hoeper, Irene Lang, Franck-Olivier Le Brun, Vallerie McLaughlin, Ralph Preiss, Lewis J. Rubin, Gérald Simonneau, Victor Tapson and Sean GaineOlivier Sitbon1Hôpital Universitaire de Bicêtre, Université Paris-Sud, Le Kremlin Bicêtre, Paris, FranceRichard Channick2Pulmonary and Critical Care, Massachusetts General Hospital, Boston, MA United StatesKelly Chin3Pulmonary Hypertension Program, UT Southwestern Medical Center, Dallas, United StatesAline Frey4Clinical Research, Actelion Pharmaceuticals Ltd, Allschwil, SwitzerlandNazzareno Galiè5Istituto di Malattie dell'Apparato Cardiovascolare, University of Bologna, Bologna, ItalyHossein-Ardeschir Ghofrani6UGMLC, University of Giessen and Marburg Lung Center, Giessen, GermanyMarius M. Hoeper7Department of Respiratory Medicine, Hannover Medical School and German Center of Lung Research, Hannover, GermanyIrene Lang8Dept of Internal Medicine II, Division of Cardiology, AKH, Medical University of Vienna, Vienna, AustriaFranck-Olivier Le Brun4Clinical Research, Actelion Pharmaceuticals Ltd, Allschwil, SwitzerlandVallerie McLaughlin9Division of Cardiovascular Medicine, University of Michigan Health System, Ann Arbor, United StatesRalph Preiss4Clinical Research, Actelion Pharmaceuticals Ltd, Allschwil, SwitzerlandLewis J. Rubin10Division of Pulmonary and Critical Care Medicine, University of California, San Diego, United StatesGérald Simonneau1Hôpital Universitaire de Bicêtre, Université Paris-Sud, Le Kremlin Bicêtre, Paris, FranceVictor Tapson11Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United StatesSean Gaine12National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland
- Rare Diseases of the Respiratory System
Edited by Thomas O.F. Wagner, Marc Humbert, Marlies Wijsenbeek, Michael Kreuter and Helge HebestreitBook | Published in 2023DOI: 10.1183/2312508X.erm10023ISBN (electronic): 978-1-84984-167-2Thomas O.F. WagnerMarc HumbertMarlies WijsenbeekMichael Kreuter
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
